BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24742492)

  • 1. TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.
    D'Costa ZC; Higgins C; Ong CW; Irwin GW; Boyle D; McArt DG; McCloskey K; Buckley NE; Crawford NT; Thiagarajan L; Murray JT; Kennedy RD; Mulligan KA; Harkin DP; Waugh DJ; Scott CJ; Salto-Tellez M; Williams R; Mullan PB
    Oncotarget; 2014 Mar; 5(6):1609-20. PubMed ID: 24742492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-box 2 represses NDRG1 through an EGR1-dependent mechanism to drive the proliferation of breast cancer cells.
    Redmond KL; Crawford NT; Farmer H; D'Costa ZC; O'Brien GJ; Buckley NE; Kennedy RD; Johnston PG; Harkin DP; Mullan PB
    Oncogene; 2010 Jun; 29(22):3252-62. PubMed ID: 20348948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of legumain and cystatin 6 expression at the maternal-fetal interface in pigs.
    Shim J; Seo H; Choi Y; Yoo I; Lee CK; Hyun SH; Lee E; Ka H
    Mol Reprod Dev; 2013 Jul; 80(7):570-80. PubMed ID: 23686917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TBX2 interacts with heterochromatin protein 1 to recruit a novel repression complex to EGR1-targeted promoters to drive the proliferation of breast cancer cells.
    Crawford NT; McIntyre AJ; McCormick A; D'Costa ZC; Buckley NE; Mullan PB
    Oncogene; 2019 Aug; 38(31):5971-5986. PubMed ID: 31253870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cystatin M/E-cathepsin L balance is essential for tissue homeostasis in epidermis, hair follicles, and cornea.
    Zeeuwen PL; van Vlijmen-Willems IM; Cheng T; Rodijk-Olthuis D; Hitomi K; Hara-Nishimura I; John S; Smyth N; Reinheckel T; Hendriks WJ; Schalkwijk J
    FASEB J; 2010 Oct; 24(10):3744-55. PubMed ID: 20495178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent loss of cystatin E/M expression implicated in the progression of prostate cancer.
    Pulukuri SM; Gorantla B; Knost JA; Rao JS
    Oncogene; 2009 Aug; 28(31):2829-38. PubMed ID: 19503093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential secretome analysis reveals CST6 as a suppressor of breast cancer bone metastasis.
    Jin L; Zhang Y; Li H; Yao L; Fu D; Yao X; Xu LX; Hu X; Hu G
    Cell Res; 2012 Sep; 22(9):1356-73. PubMed ID: 22688893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CST6 protein and peptides inhibit breast cancer bone metastasis by suppressing CTSB activity and osteoclastogenesis.
    Li X; Liang Y; Lian C; Peng F; Xiao Y; He Y; Ma C; Wang Y; Zhang P; Deng Y; Su Y; Luo C; Kong X; Yang Q; Liu T; Hu G
    Theranostics; 2021; 11(20):9821-9832. PubMed ID: 34815788
    [No Abstract]   [Full Text] [Related]  

  • 9. TBX2 acts as a potent transcriptional silencer of tumour suppressor genes through interaction with the CoREST complex to sustain the proliferation of breast cancers.
    McIntyre AJ; Angel CZ; Smith JS; Templeman A; Beattie K; Beattie S; Ormrod A; Devlin E; McGreevy C; Bothwell C; Eddie SL; Buckley NE; Williams R; Mullan PB
    Nucleic Acids Res; 2022 Jun; 50(11):6154-6173. PubMed ID: 35687133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over-expression of cysteine proteinase inhibitor cystatin 6 promotes pancreatic cancer growth.
    Hosokawa M; Kashiwaya K; Eguchi H; Ohigashi H; Ishikawa O; Furihata M; Shinomura Y; Imai K; Nakamura Y; Nakagawa H
    Cancer Sci; 2008 Aug; 99(8):1626-32. PubMed ID: 18754876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-level internalization of cystatin E/M affects legumain activity and migration of melanoma cells.
    Wallin H; Apelqvist J; Andersson F; Ekström U; Abrahamson M
    J Biol Chem; 2017 Sep; 292(35):14413-14424. PubMed ID: 28630039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleoplasmic calcium regulates cell proliferation through legumain.
    Andrade V; Guerra M; Jardim C; Melo F; Silva W; Ortega JM; Robert M; Nathanson MH; Leite F
    J Hepatol; 2011 Sep; 55(3):626-635. PubMed ID: 21237226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss-of-function mutations in CST6 cause dry skin, desquamation and abnormal keratosis without hypotrichosis.
    Wang X; Liu J; Chen J; Xu X; Zhong Y; Xu Y; Lu P; Zhou J; Lin Z; Yang B; Yang C
    Clin Genet; 2023 Mar; 103(3):301-309. PubMed ID: 36371786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation of cystatin M promoter is associated with unfavorable prognosis in operable breast cancer.
    Kioulafa M; Balkouranidou I; Sotiropoulou G; Kaklamanis L; Mavroudis D; Georgoulias V; Lianidou ES
    Int J Cancer; 2009 Dec; 125(12):2887-92. PubMed ID: 19551853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Overview of Targeting Legumain for Inhibiting Cancers.
    Reddy BD; Beeraka NM; Chitturi CMK; Madhunapantula SV
    Curr Pharm Des; 2021 Oct; 27(31):3337-3348. PubMed ID: 33238867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of silencing the T‑Box transcription factor TBX2 in prostate cancer PC3 and LNCaP cells.
    Du WL; Fang Q; Chen Y; Teng JW; Xiao YS; Xie P; Jin B; Wang JQ
    Mol Med Rep; 2017 Nov; 16(5):6050-6058. PubMed ID: 28849151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-proliferative function of the TGF-β1 signaling pathway involves the repression of the oncogenic TBX2 by its homologue TBX3.
    Li J; Ballim D; Rodriguez M; Cui R; Goding CR; Teng H; Prince S
    J Biol Chem; 2014 Dec; 289(51):35633-43. PubMed ID: 25371204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The T box transcription factor TBX2 promotes epithelial-mesenchymal transition and invasion of normal and malignant breast epithelial cells.
    Wang B; Lindley LE; Fernandez-Vega V; Rieger ME; Sims AH; Briegel KJ
    PLoS One; 2012; 7(7):e41355. PubMed ID: 22844464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXO transcription factors control E2F1 transcriptional specificity and apoptotic function.
    Shats I; Gatza ML; Liu B; Angus SP; You L; Nevins JR
    Cancer Res; 2013 Oct; 73(19):6056-67. PubMed ID: 23966291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone Metastasis of Prostate Cancer Can Be Therapeutically Targeted at the TBX2-WNT Signaling Axis.
    Nandana S; Tripathi M; Duan P; Chu CY; Mishra R; Liu C; Jin R; Yamashita H; Zayzafoon M; Bhowmick NA; Zhau HE; Matusik RJ; Chung LW
    Cancer Res; 2017 Mar; 77(6):1331-1344. PubMed ID: 28108510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.